Novel Therapeutic Targets in Multiple Myeloma

Francesca Cottini, MD, and Kenneth Anderson, MD

Clinical Advances in Hematology & Oncology April 2015, Volume13, Issue 4 Novel Therapeutic Targets in Multiple Myeloma Francesca Cottini, MD, and Kenneth Anderson, MD Dr Cottini […]

Curative Treatment for Severe Sickle Cell Disease: Allogeneic Transplantation

Benjamin Oshrine, MD, and Julie-An Talano, MD

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   Curative Treatment for Severe Sickle Cell Disease: Allogeneic Transplantation Benjamin Oshrine, MD, and […]

Families With Both Hodgkin Lymphoma and Multiple Myeloma in Their Pedigrees

Peter H. Wiernik, MD, Dona Wickramasinghe, MD, and Janice P. Dutcher, MD

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   Families With Both Hodgkin Lymphoma and Multiple Myeloma in Their Pedigrees Peter H. […]

Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer Erica L. Mayer, […]

Combination Therapies for Treating Metastatic Melanoma

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   Hussein Tawbi, MD, PhD Associate Professor of Medicine, Clinical & Translational Science, University […]

New Developments in Richter Syndrome

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   New Developments in Richter Syndrome Nitin Jain, MD, Assistant Professor, Department of Leukemia, […]

New Drugs in Ovarian Cancer

Clinical Advances in Hematology & Oncology April 2014, Volume 13, Issue 4   New Drugs in Ovarian Cancer Gini F. Fleming, MD, Professor of Medicine, Director […]

The Role of Sorafenib in Hepatocellular Carcinoma

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   The Role of Sorafenib in Hepatocellular Carcinoma Pierre Gholam, MD, Associate Professor of […]

FDA News

Kathryn Turner, PhD

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   By Kathryn Turner, PhD   FDA Approves Panobinostat for Relapsed Multiple Myeloma Panobinostat […]

Hem/Onc News

Kathryn Turner, PhD

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   By Kathryn Turner, PhD   FDA Approves First US Biosimilar The US Food […]

Letter From the Editor

Bruce D. Cheson, MD

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4   Inside My File Cabinets We finally have emerged from the dungeon, and are […]

Back to Archive